{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T03:07:38Z","timestamp":1790996858180,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"National Key Technologies R&D Program for New Drugs","award":["2012ZX09301003-001-009"],"award-info":[{"award-number":["2012ZX09301003-001-009"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.biopha.2015.05.002","type":"journal-article","created":{"date-parts":[[2015,5,20]],"date-time":"2015-05-20T19:05:53Z","timestamp":1432148753000},"page":"6-11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":75,"special_numbering":"C","title":["Improved anti-melanoma effect of a transdermal mitoxantrone ethosome gel"],"prefix":"10.1016","volume":"73","author":[{"given":"Xiang","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guiying","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3528-1397","authenticated-orcid":false,"given":"Yiguang","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.biopha.2015.05.002_bib0180","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.ctrv.2013.04.006","article-title":"Immunotherapy for advanced melanoma: fulfilling the promise","volume":"39","author":"Gogas","year":"2013","journal-title":"Cancer Treat. Rev."},{"issue":"12","key":"10.1016\/j.biopha.2015.05.002_bib0185","first-page":"1565","article-title":"Pharmacodynamics, pharmacokinetics and tissue distribution of liposomal mitoxantrone hydrochloride","volume":"45","author":"Wang","year":"2010","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.biopha.2015.05.002_bib0190","first-page":"653","article-title":"Anacardic acid enhances the anticancer activity of liposomal mitoxantrone towards melanoma cell lines-in vitro studies","volume":"9","author":"Legut","year":"2014","journal-title":"Int. J. Nanomedicine"},{"issue":"1","key":"10.1016\/j.biopha.2015.05.002_bib0195","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/nm1523","article-title":"Calreticulin exposure dictates the immunogenicity of cancer cell death","volume":"13","author":"Obeid","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.biopha.2015.05.002_bib0200","doi-asserted-by":"crossref","first-page":"e826","DOI":"10.1038\/cddis.2013.372","article-title":"Calreticulin surface exposure is abrogated in cells lacking, chaperone-mediated autophagy-essential gene, LAMP2A","volume":"4","author":"Garg","year":"2013","journal-title":"Cell Death Dis."},{"issue":"2","key":"10.1016\/j.biopha.2015.05.002_bib0205","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.pjnns.2013.12.005","article-title":"The N-terminal pro-brain natriuretic peptide as a marker of mitoxantrone-induced cardiotoxicity in multiple sclerosis patients","volume":"48","author":"Podlecka-Pietowska","year":"2014","journal-title":"Neurol. Neurochir. Pol."},{"issue":"12","key":"10.1016\/j.biopha.2015.05.002_bib0210","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1016\/0959-8049(92)90241-S","article-title":"Unexpected prolonged myelosuppression after mitomycin, mitoxantrone and methotrexate","volume":"28A","author":"Muhonen","year":"1992","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.biopha.2015.05.002_bib0215","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ijpharm.2013.10.023","article-title":"Pegylated liposomal mitoxantrone is more therapeutically active than mitoxantrone in L1210 ascitic tumor and exhibits dose-dependent activity saturation effect","volume":"460","author":"Li","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.biopha.2015.05.002_bib0220","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s00280-014-2523-8","article-title":"Phase I clinical trial of pegylated liposomal mitoxantrone plm60-s: pharmacokinetics, toxicity and preliminary efficacy","volume":"74","author":"Yang","year":"2014","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.biopha.2015.05.002_bib0225","doi-asserted-by":"crossref","first-page":"328","DOI":"10.3109\/1061186X.2012.750325","article-title":"Specific targeting of cancer cells by multifunctional mitoxantrone-conjugated magnetic nanoparticles","volume":"21","author":"Heidari","year":"2013","journal-title":"J. Drug Target."},{"issue":"1","key":"10.1016\/j.biopha.2015.05.002_bib0230","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v20.i1.20","article-title":"Ethosomes: new prospects in transdermal delivery","volume":"20","author":"Godin","year":"2003","journal-title":"Crit. Rev. Ther. Drug Carrier Syst."},{"issue":"1","key":"10.1016\/j.biopha.2015.05.002_bib0235","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3109\/10717544.2012.752420","article-title":"A study on ethosomes as mode for transdermal delivery of an antidiabetic drug","volume":"20","author":"Bodade","year":"2013","journal-title":"Drug Deliv."},{"key":"10.1016\/j.biopha.2015.05.002_bib0240","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1213\/ANE.0b013e3182937b74","article-title":"Formulation and evaluation of lidocaine base ethosomes for transdermal delivery","volume":"117","author":"Zhu","year":"2013","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.biopha.2015.05.002_bib0245","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.ijpharm.2014.06.001","article-title":"Comparison of ethosomes and liposomes for skin delivery of psoralen for psoriasis therapy","volume":"471","author":"Zhang","year":"2014","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.biopha.2015.05.002_bib0250","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jconrel.2007.08.005","article-title":"Dermal and transdermal delivery of an anti-psoriatic agent via ethanolic liposomes","volume":"123","author":"Dubey","year":"2007","journal-title":"J. Control. Release"},{"issue":"2","key":"10.1016\/j.biopha.2015.05.002_bib0255","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.nano.2011.06.007","article-title":"Novel nanostructured lipid-dextran sulfate hybrid carriers overcome tumor multidrug resistance of mitoxantrone hydrochloride","volume":"8","author":"Zhang","year":"2012","journal-title":"Nanomedicine"},{"issue":"11","key":"10.1016\/j.biopha.2015.05.002_bib0260","first-page":"925","article-title":"Solid lipid nanoparticles of anticancer drugs against MCF-7 cell line and a murine breast cancer model","volume":"67","author":"Zhuang","year":"2012","journal-title":"Pharmazie"},{"issue":"2","key":"10.1016\/j.biopha.2015.05.002_bib0265","doi-asserted-by":"crossref","first-page":"65","DOI":"10.4103\/2230-973X.133053","article-title":"Enhanced transdermal permeability of piroxicam through novel nanoemulgel formulation","volume":"4","author":"Dhawan","year":"2014","journal-title":"Int. J. Pharm. Invest."},{"issue":"1\u20132","key":"10.1016\/j.biopha.2015.05.002_bib0270","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ijpharm.2014.03.013","article-title":"Transdermal enhancement effect and mechanism of iontophoresis for non-steroidal anti-inflammatory drugs","volume":"466","author":"Zuo","year":"2014","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.biopha.2015.05.002_bib0275","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1097\/CAD.0b013e32835920fa","article-title":"A functionalized poly(amidoamine) nanocarrier loading 5-fluorouracil: pH-responsive drug release and enhanced anticancer effect","volume":"24","author":"Du","year":"2013","journal-title":"Anticancer. Drugs"},{"issue":"8","key":"10.1016\/j.biopha.2015.05.002_bib0280","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1158\/1535-7163.MCT-10-0172","article-title":"Systemic administration of polymeric nanoparticle-encapsulated curcumin (NanoCurc) blocks tumor growth and metastases in preclinical models of pancreatic cancer","volume":"9","author":"Bisht","year":"2010","journal-title":"Mol. Cancer Ther."},{"issue":"3","key":"10.1016\/j.biopha.2015.05.002_bib0285","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.anndiagpath.2014.03.001","article-title":"Electronic expert consultation using digital still images for evaluation of atypical small acinar proliferations of the prostate: a comparison with immunohistochemistry","volume":"18","author":"Banihashemi","year":"2014","journal-title":"Ann. Diagn. Pathol."},{"issue":"5","key":"10.1016\/j.biopha.2015.05.002_bib0290","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/cyto.b.21028","article-title":"Flow cytometry-based assessment of mitoxantrone efflux from leukemic blasts varies with response to induction chemotherapy in acute myeloid leukemia","volume":"82","author":"Kim","year":"2012","journal-title":"Cytometry B. Clin. Cytom."},{"key":"10.1016\/j.biopha.2015.05.002_bib0295","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.colsurfb.2013.08.021","article-title":"Nanoassemblies containing a fluorouracil\/zidovudine glyceryl prodrug with phospholipase A2-triggered drug release for cancer treatment","volume":"112","author":"Jin","year":"2013","journal-title":"Colloids Surf. B. Biointerfaces"},{"issue":"7","key":"10.1016\/j.biopha.2015.05.002_bib0300","doi-asserted-by":"crossref","first-page":"e102850","DOI":"10.1371\/journal.pone.0102850","article-title":"The effect of nanoemulsion as a carrier of hydrophilic compound for transdermal delivery","volume":"9","author":"Tsai","year":"2014","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.biopha.2015.05.002_bib0305","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/cmi.2009.59","article-title":"Mitoxantrone-mediated apoptotic B16-F1 cells induce specific anti-tumor immune response","volume":"6","author":"Cao","year":"2009","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.biopha.2015.05.002_bib0310","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1600-065X.2007.00567.x","article-title":"Ecto-calreticulin in immunogenic chemotherapy","volume":"220","author":"Obeid","year":"2007","journal-title":"Immunol. Rev."},{"issue":"1\u20132","key":"10.1016\/j.biopha.2015.05.002_bib0315","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0378-5173(02)00084-4","article-title":"Estimation of intradermal disposition kinetics of drugs: II, factors determining penetration of drugs from viable skin to muscular layer","volume":"239","author":"Higaki","year":"2002","journal-title":"Int. J. Pharm."},{"issue":"3","key":"10.1016\/j.biopha.2015.05.002_bib0320","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1089\/108076801750295245","article-title":"Plasma concentration of topically applied betaxolol in elderly glaucoma patients","volume":"17","author":"Vainio-Jylha","year":"2001","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.biopha.2015.05.002_bib0325","doi-asserted-by":"crossref","first-page":"254","DOI":"10.3109\/08982104.2012.690158","article-title":"Ultradeformable liposomes with terpenes for delivery of hydrophilic compound","volume":"22","author":"Subongkot","year":"2012","journal-title":"J. Liposome Res."},{"issue":"4","key":"10.1016\/j.biopha.2015.05.002_bib0330","doi-asserted-by":"crossref","first-page":"E111","DOI":"10.1208\/pt0804111","article-title":"Formulation and evaluation of ethosomes for transdermal delivery of lamivudine","volume":"8","author":"Jain","year":"2007","journal-title":"AAPS PharmSciTech"},{"issue":"4","key":"10.1016\/j.biopha.2015.05.002_bib0335","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1089\/adt.2004.2.363","article-title":"Application of real-time cell electronic sensing (RT-CES) technology to cell-based assays","volume":"2","author":"Solly","year":"2004","journal-title":"Assay Drug Dev. Tech."},{"issue":"1","key":"10.1016\/j.biopha.2015.05.002_bib0340","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1006\/excr.2000.4919","article-title":"Electric cell-substrate impedance sensing (ECIS) as a noninvasive means to monitor the kinetics of cell spreading to artificial surfaces","volume":"259","author":"Wegener","year":"2000","journal-title":"Exp. Cell Res."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332215001146?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332215001146?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T10:56:53Z","timestamp":1760093813000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332215001146"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":33,"alternative-id":["S0753332215001146"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2015.05.002","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Improved anti-melanoma effect of a transdermal mitoxantrone ethosome gel","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2015.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}